← Back to Search

Behavioural Intervention

Nu-V3 for Chronic Pain (Nu-V3P2RCT Trial)

N/A
Waitlist Available
Led By Vipul Kella, MD
Research Sponsored by Nu-Life Solutions
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 and 24 weeks
Awards & highlights

Nu-V3P2RCT Trial Summary

This trial is testing a new device to see if it can help people with chronic pain, anxiety, depression, and/or sleeplessness.

Eligible Conditions
  • Chronic Pain
  • Anxiety
  • Depression
  • Insomnia

Nu-V3P2RCT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 and 24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effectiveness and overall change in reported primary symptom of concern: Anxiety
Effectiveness and overall change in reported primary symptom of concern: Chronic Pain
Effectiveness and overall change in reported primary symptom of concern: Depression
+2 more
Secondary outcome measures
Effectiveness: Symptom Frequency
Effectiveness: Symptom Severity

Nu-V3P2RCT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Nu-V3 treatment armExperimental Treatment1 Intervention
Treatment with the Nu-V3 Device.
Group II: Observation treatment arm (SOC, control)Active Control1 Intervention
Observation following stable standard of care.

Find a Location

Who is running the clinical trial?

Nu-Life SolutionsLead Sponsor
1 Previous Clinical Trials
16 Total Patients Enrolled
1 Trials studying Chronic Pain
16 Patients Enrolled for Chronic Pain
Vipul Kella, MDPrincipal InvestigatorNu-Life Solutions
Eric T. Siebeneck, MSStudy DirectorNu-Life Solutions

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are opportunities for patient participation in this trial still available?

"According to the information provided on clinicaltrials.gov, this specific trial is no longer recruiting participants. After first being posted in June 2022 and last edited a few days later, it has since closed its doors for recruitment but 2231 alternative trials are actively seeking hopeful candidates at present."

Answered by AI

Who else is applying?

What state do they live in?
Illinois
Wisconsin
Other
Indiana
What site did they apply to?
Greater Chicago Specialty Physicians (GCSP) - Schamuburg
EZ Clinic
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
2
0
3+

Why did patients apply to this trial?

I have tried many drugs that didn’t help. Pain issues not helped with other medications.
PatientReceived 2+ prior treatments
I discovered this clinical trial while researching alternative (non pharmaceutical) methods of treating anxiety and depression.
PatientReceived 2+ prior treatments
I was diagnosed with Fibromyalgia in 2019, after dealing with unexplained chronic pain for 2yrs already. Trying to find other methods and treatments to manage the pain levels.
PatientReceived 2+ prior treatments
I have been on prozak, Zoloft, celexa (which this medicine gave me hives inside my body from being allergic, had to get benadryl shot). I hate taking pills I would love to find a option that would be possible to be pill free thank you for your consideration!
PatientReceived 1 prior treatment

What questions have other patients asked about this trial?

I am currently active in counseling and am taking 40/mg of fluoxetine and 60/mg of propranolol daily... would these medications prevent me from eligibility?
PatientReceived 1 prior treatment
Recent research and studies
clinicaltrials.govStudy
Phase II Trial of Nu-V3 Non-Invasive Nerve Stimulation Device for Chronic Pain, Anxiety, Depression, Sleeplessness
2024. "Phase II Trial of Nu-V3 Non-Invasive Nerve Stimulation Device for Chronic Pain, Anxiety, Depression, Sleeplessness". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05394545.
~53 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top